Lung transplantation has developed significantly in recent years, but post-transplant care
and patients' survival still need to be improved. Moreover, organ shortage urges novel …

Immune rejection remains the major obstacle to long-term survival of allogeneic lung
transplants. The expression of major histocompatibility complex molecules and minor …

Problem Preeclampsia is a heterogeneous syndrome of diverse etiologies and molecular
pathways leading to distinct clinical subtypes. Herein, we aimed to characterize the …

Acute allograft rejection after lung transplantation significantly increases the risk of
developing bronchiolitis obliterans syndrome, BOS, a form of chronic lung allograft …

Abstract The Lung Session of the 2022 16th Banff Foundation for Allograft Pathology
Conference—held in Banff, Alberta—focused on non-rejection lung allograft pathology and …

Rationale: Chronic lung allograft dysfunction (CLAD) is the leading cause of death following
lung transplant, and azithromycin has variable efficacy in CLAD. The lung microbiome is a …

Background Surveillance bronchoscopies with bronchoalveolar lavage (BAL) and
transbronchial biopsies (TBB) are primarily used to detect acute cellular rejection (ACR) or …

Background: Transbronchial cryobiopsy (TBCB) provides larger tissue samples and
improved sampling depth, but its role in diagnosing acute cellular rejection (ACR) in lung …

The long-term benefits of lung transplantation (LTx) are limited by pathogenic alloimmune
responses that drive injury, inflammation, and chronic dysfunction. Human leukocyte antigen …

Résumé La transplantation pulmonaire est actuellement acceptée comme traitement
potentiel des maladies respiratoires en stade terminal. Les complications bronchiques et …